Together, these effects support the repair of damaged nerves and lower pain (Guo et al., 2022
The general public may not always be able to distinguish between regulated and unregulated products
Arulrajah, B., Muhialdin, B.J., Qoms, M.S., Zarei, M., Hussin, A., Hasan, H., et al., Int
(2018) reviewed BPC-157s effects on the brain-gut axis in Current Neuropharmacology (PMID: 28707506), documenting protective effects against NSAIDinduced gastric lesions, inflammatory bowel disease models, and neurological injury models
What changed in 20232026 (and why everyones confused) The peptide landscape shifted sharply between 2023 and 2026: the FDA restricted roughly 19 peptides in 2023, then in 2026 began reversing course but removed from the restricted list is not the same as FDA-approved. The timeline is worth knowing, because most of what youll read online is out of date: 2023 the restriction